Ledyard National Bank Abb Vie Inc. Transaction History

Ledyard National Bank

$1.06 Billion
Q4 2024

A detailed history of Ledyard National Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Ledyard National Bank holds 20,654 shares of ABBV stock, worth $4.17 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

20,654

Previous 20,626 0.14%

Holding current value

$4.17 Million

Previous $4.07 Million 9.89%

% of portfolio

0.35%

Previous 0.37%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	BUY	$164.99 - $203.87 $4,619 - $5,708	28 Added 0.14%	20,654 $3.67 Million
Q3 2024 Oct 21, 2024	BUY	$163.84 - $199.33 $128,942 - $156,872	787 Added 3.97%	20,626 $4.07 Million
Q2 2024 Aug 05, 2024	BUY	$154.79 - $180.76 $8,977 - $10,484	58 Added 0.29%	19,839 $3.4 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $16,781 - $19,120	-105 Reduced 0.53%	19,781 $3.6 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $393,398 - $443,059	2,859 Added 16.79%	19,886 $3.08 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $1,068 - $1,237	-8 Reduced 0.05%	17,027 $2.54 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $36,970 - $46,007	-279 Reduced 1.61%	17,035 $2.3 Million
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $80,258 - $92,429	-555 Reduced 3.11%	17,314 $2.76 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $15,214 - $18,245	-110 Reduced 0.61%	17,869 $2.89 Million
Q3 2022 Oct 18, 2022	SELL	$134.21 - $153.93 $66,299 - $76,041	-494 Reduced 2.67%	17,979 $2.41 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $143,812 - $182,833	-1,045 Reduced 5.35%	18,473 $2.83 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $50,812 - $63,043	-385 Reduced 1.93%	19,518 $3.16 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $285,978 - $361,845	-2,662 Reduced 11.8%	19,903 $2.7 Million
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $264,829 - $300,621	-2,489 Reduced 9.93%	22,565 $2.43 Million
Q2 2021 Jul 27, 2021	SELL	$105.21 - $117.21 $44,819 - $49,931	-426 Reduced 1.67%	25,054 $2.82 Million
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $221,786 - $244,160	2,168 Added 9.3%	25,480 $2.76 Million
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $59,562 - $80,415	-740 Reduced 3.08%	23,312 $2.5 Million
Q3 2020 Oct 21, 2020	SELL	$85.91 - $100.83 $42,783 - $50,213	-498 Reduced 2.03%	24,052 $2.11 Million
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $3,521 - $4,712	48 Added 0.2%	24,550 $2.41 Million
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $42,118 - $63,856	-653 Reduced 2.6%	24,502 $1.87 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $7,140 - $8,934	99 Added 0.4%	25,155 $2.23 Million
Q3 2019 Oct 23, 2019	SELL	$62.98 - $75.72 $49,754 - $59,818	-790 Reduced 3.06%	25,056 $1.9 Million
Q2 2019 Jul 26, 2019	SELL	$65.7 - $83.98 $69,642 - $89,018	-1,060 Reduced 3.94%	25,846 $1.88 Million
Q1 2019 Apr 12, 2019	SELL	$77.14 - $90.79 $98,353 - $115,757	-1,275 Reduced 4.52%	26,906 $2.17 Million
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $24,600 - $30,339	-316 Reduced 1.11%	28,181 $2.6 Million
Q3 2018 Oct 24, 2018	SELL	$88.91 - $98.84 $41,432 - $46,059	-466 Reduced 1.61%	28,497 $2.7 Million
Q2 2018 Jul 11, 2018	SELL	$89.78 - $106.23 $81,250 - $96,138	-905 Reduced 3.03%	28,963 $2.68 Million
Q1 2018 Apr 16, 2018	SELL	$92.01 - $123.21 $3,404 - $4,558	-37 Reduced 0.12%	29,868 $2.83 Million
Q4 2017 Jan 30, 2018	SELL	$89.56 - $98.21 $228,646 - $250,730	-2,553 Reduced 7.87%	29,905 $2.89 Million
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $2.27 Million - $2.9 Million	32,458	32,458 $2.88 Million

Others Institutions Holding ABBV

# of Institutions

4,095

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Ledyard National Bank with notifications on news.

Account

Ledyard National Bank Abb Vie Inc. Transaction History